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Introduction
Data on medication-related unplanned admissions 
 suggest that there is ample opportunity to improve 
 pharmaceutical care. A systematic review reported 
that 7.1% of unplanned admissions were medication-
related of which 59% were considered preventable [1]. 
The Dutch prospective multi-center study of Hospital 
Admissions Related to Medication (HARM) reported 
similar results with 5.6% of unplanned admissions being 
medication-related, of which nearly half were consid-
ered preventable [2]. The number of medication-related 
 hospital  admissions increases up to 10.4% within the 
aging  population [3].
Pharmacists can play a vital role to address the  problem 
of medication-related harm. In recent years, we have seen 
a profound change in the role of community pharmacists. 
Their role has shifted from compounding and dispens-
ing medications to providing integrated pharmaceutical 
care [4, 5]. The concept of pharmaceutical care empha-
sizes the pharmacists’ responsibility to pursue the best 
possible patient outcomes of medication therapy [6, 7]. 
The implementation of pharmaceutical care may be ham-
pered by traditional activities of pharmacists, related to 
the logistics and counseling of dispensing of medica-
tion. Embedding non-dispensing pharmacists (NDPs, 
also called clinical pharmacists, practice pharmacists) in 
general practice enables pharmacists not to be distracted 
from logistics but to primarily contribute to the quality of 
pharmaceutical care. Non-dispensing pharmacist are spe-
cialized health care professionals who perform patient-
centered activities and services to develop and promote 
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the rational and appropriate use of medication [8], and 
who are not involved in the dispensing of medication.
NDP-led services improve the quality of medications’ use 
and are increasingly implemented in the United States, 
Canada, Australia and the United Kingdom [9–12]. The key 
aspects of such an integrated care model are: being a team 
member, having access to medical records and perform-
ing medication therapy management. As a team member 
of a general practice, the NDP can easily contact the GP 
which fosters understanding and trust. Access to the medi-
cal records of patients supports pharmaceutical care pro-
vision and facilitates communication between NDPs and 
GPs [13–15]. Last but not least, the work of the NDPs is 
clinically focused, consisting of clinical medication reviews, 
consultations for medication related questions and tar-
geted pharmaceutical care  programs to systematically 
improve the quality of prescribing. It starts with individual 
or population-based problem identification and subse-
quently targets the problem in a patient-centered way.
The POINT practice model [16] incorporated key ele-
ments of the Canadian IMPACT model of NDP-care [17] 
(see ‘activities’, Figure 1) and assured alignment to the 
prevailing vision of pharmaceutical care provision [6, 7]. 
In addition to the key elements we described in the for-
mer paragraph, we added two elements for the Dutch 
context, namely a fixed income and a training program. 
The fixed income made the NDP financially independent 
of dispensing of medication. The NDPs were trained by 
pharmacists and GPs in a primary care based clinical phar-
macy training program [17] (See Input, Figure 1)
As the evidence for the benefits of this new role of phar-
macists on real clinical endpoints such as mortality or 
medication-related hospitalisations is unknown [18], the 
POINT study group conducted a controlled intervention 
study, comparing clinical outcomes between NDP-led care 
and current models of pharmaceutical care delivery in the 
Netherlands. NDP-led care is new in the Netherlands
Measuring the clinical effectiveness of such a complex 
intervention is challenging given the variety of NDP-led 
services and different health care professionals involved. 
Hence, for optimal interpretation of the data, i.e. whether 
and how NDP-led care improves medication safety, we 
needed to describe the operational aspects of the interven-
tion in detail [19]. The success of an integrated care model 
will be dependent on how the health care professionals 
collaborate, how work processes will be aligned and how 
tasks are reallocated. Therefore, in this particular study, 
we deliberately choose to focus on the process of clini-
cal integration of the NDPs by observing their interactions 
with other health professionals in the primary care team. 
The aim of this paper was to give a systematic description 
of what is entailed in integrating an NDP as a member 
of the primary care team and how the integration could 
 contribute to the safe and effective use of medication.
Background
In the Netherlands, pharmaceutical care in primary care is 
currently provided by community pharmacists. The typical 
Dutch community pharmacy serves approximately 9,000 
patients with one or two community pharmacists and 
eight pharmacy technicians delivering medication and 
health-related products. Dutch community pharmacists 
focus on counselling and dispensing of prescription medi-
cation. The majority of Over-The-Counter medication, 
food supplements and cosmetics are distributed through 
so called drugstores. In addition to dispensing fees, health 
care authorities have introduced a limited number of fees 
for pharmaceutical care services. In addition, community 
pharmacists can receive a higher dispensing fee if they 
score better on a selection of quality of care indicators.
Figure 1: The preliminary program theory of clinical integration of NDPs in general practice.
Input 
• Co-location of the NDP in general practice 
• Shared access to medical data  
• Fixed income of NDP independent of dispensing of medication
• Participation of NDP in a primary care based clinical pharmacy training program 
Activities 
 
• Patient-level: Clinical medication review and reconcilliation, patient consultations 
• Provider-level: Medication management advise and education in pharmacotherapy  
• Practice-level: Implementing pharmaceutical care projects on appropriate prescribing 
and medication use, and streamlining care processes. 
 
Output 
• Shared decision-making around patients' pharmacotherapy 
• Sharing of knowledge 
Outcomes 
• Improved quality and safety of medication 
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General practice care in the Netherlands is increasingly 
organized in group practices. These group practices are 
at their turn increasingly located in community health 
centers together with community pharmacists, practice 
nurses and other health care providers. On average three 
to five general practitioners (GPs) with an extensive auxil-
iary staff provide primary care to 6,000–10,000 patients. 
GPs are paid by capitation (60%) and fee for service (40%), 
mainly consultations of ten minutes each. GPs receive 
bonus funding from insurance companies to meet the 
predefined quality of care indicators. Most GPs employ 
practice nurses specialized in chronic illnesses such as 
diabetes, cardiovascular disease and chronic obstructive 
pulmonary disease, and mental health staff addressing 
psychosocial problems. In addition to practice nurses, GPs 
employ practice assistants who do most of the triage, prac-
tice administration, and simple procedures.
Methods
Study design
We reconstructed the program theory of the integration 
of NDPs in general practice [20]. A program theory is a 
systematic description of what an intervention entails, 
how its elements link to the intended outcomes and how 
the intervention interacts with the context [19]. We distin-
guished in our preliminary program theory the input, the 
activities, the output and the outcomes. The input was: co-
location of NDPs, shared medical records, a fixed income 
and participation of the NDP in a clinical pharmacy 
training program. The activities were: clinical medica-
tion reviews for patients with polypharmacy, medication 
reconciliation for patients discharged from the hospital, 
patient consultations about specific medication-therapy 
problems and targeted pharmaceutical care programs. 
The output was clinical integration in terms of knowledge 
sharing and shared decision making. The outcome was 
medication safety (See Figure 1).
Setting and participants
Our unit of analysis were nine different NDPs. For a period 
of 15 months, these NDPs – all with previous work experi-
ence in community pharmacy – were posted in nine gen-
eral practices [16]. Concurrently, the NDPs participated 
in an extensive general practice based Clinical Pharmacy 
Training Program to be prepared to work at the clinical 
side of primary care [17].
Data collection
We trained the nine NDPs to do participative observa-
tions. These consisted of observing and describing any 
professional encounter during their work, e.g. conversa-
tions at lunchtime meetings on pharmaceutical care, the 
questions that GPs asked them during work, the reflec-
tions of the practice nurses and the practice assistants to 
their work and the role of managerial expertise in their 
work. The focus of the observations was defined upon 
both what is known about the introduction of new profes-
sional roles as well as upon the results of the first obser-
vations. Based upon what is known about new roles, we 
asked NDPs to observe how their work interacted with and 
possibly conflicted with the work of the GPs, the practice 
nurses and the practice assistants. Therefore, we asked the 
NDPs to observe the daily work of GPs, practice nurses 
and practice assistants. We asked them in particular to 
make notes about daily organization of the work in the 
practice and the interactions between practice nurses and 
GPs. To collect notes about their professional encounters 
during their work, we designed a data collection form in 
Excel. This form consisted of four headings: successes and 
challenges related to both task performance and aspects 
of clinical integration. The NDPs sent weekly updates of 
this form to the principal investigator (AH). In addition, 
we developed assignments that were incorporated in 
the educational program, related to clinical integration. 
An example of such an assignment was to compare and 
discuss task performance and responsibilities of practice 
nurses and NDPs. These completed assignments were sent 
to the principal investigator (AH).
Finally, we asked the NDPs to record how they spend 
their time by filling in an Excel-template representing five 
working days. Each day was divided in 15 minute times-
lots. These standardized forms were filled in by the NDPs 
during three random weeks and sent to the principal 
investigator (AH) as well.
Analysis
The researchers and the NDPs had monthly meetings 
in which they jointly analyzed the ethnographic data 
[21, 22]. Although ethnographic research can refer to dif-
ferent methods of data collection and analysis, it can also 
be characterized by the – often lengthy – observation of 
interactions and behavior of participants in ‘real life set-
tings’. Two researchers (AdB and AH) jointly performed a 
manual qualitative analysis of the notes on the encoun-
ters between the NDPs and the GPs or practice nurses. 
We identified commonalities and differences between 
the encounters. We studied nine NDPs and their collab-
orating GPs and we presented a selection of excerpts to 
the NDPs during the educational sessions of their clini-
cal pharmacy training program. Subsequently, we asked 
the NDPs to reflect on the difference between successful 
and less successful encounters with regard to knowledge 
sharing and shared decision making. At the end of every 
lecture new instructions were provided for what the NDP 
needed to be noted down during their daily work in the 
clinic. For example, after the first round of observations 
the NDPs were asked to note down the questions GPs 




We asked the NDPs to make notes of the questions 
GPs asked them. These questions provided insight in 
how knowledge was shared. In the first months of the 
study, the GPs asked the NDPs questions on medication. 
The questions were short and relatively uncomplicated 
and knowledge of the patient’s context was not essential. 
For example, a GP asked the NDP how to switch from the 
antidepressant citalopram to fluoxetine, since citalopram 
was not effective. In this case, the GP had already decided 
on the choice of medication therapy and only needed 
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specific information about the best way to switch from 
one medication to the other. GPs appreciated concise and 
direct answers to these questions. The NDPs are supposed 
to mobilize pharmaceutical evidence on the spot.
After a couple of months, the GPs started sharing more 
complex cases with the NDPs. They appreciated prag-
matic solutions for patients with more complex medi-
cation related problems. A GP asked for example if and 
how the NDP should stop citalopram for a patient with 
anxiety disorder. The NDP decided to invite the patient 
for counseling to discuss current medication-related 
needs, usage and experience with the medication (effi-
cacy and side effects), concerns, potential complaints 
and the patient’s wish to stop the medication therapy. 
The NDP suggested a  tailored scheme to stop citalopram 
and the NDP monitored the patient during the process 
of stopping. GP respected NDPs to go beyond protocols 
if necessary.
Reconciliation of interprofessional tensions
Based upon the observations of the work of prac-
tice nurses, we analyzed how both the NDPs and the 
 practice nurses reconciled interprofessional tensions 
over responsibilities and domain discussions. We recon-
structed two strategies. The first strategy is to support 
the practice nurses in – what they call – difficult cases. 
NDPs take over the provision of pharmaceutical care to 
those patients who either did not fit well in the proto-
col or who used a  medication that could be potentially 
dangerous. This strategy aimed to ease the work of the 
practice nurses. The following example was presented as 
a success by an NDP in her new role.
“The practice nurse referred a patient to the NDP. 
After three  consultations, which resulted in adjust-
ing  antihypertensive  medication, extra lab moni-
toring,  stopping amitriptyline and starting vitamin 
B12, the patient was referred back to the practice 
nurse. I explained the medication changes to the 
practice nurse. The practice nurse said she appre-
ciated our efficient collaboration and the insights 
into medication therapy. She added that she liked 
it that I (NDP) was so approachable.” (field notes of 
the NDP).
Another NDP explained:
“A practice nurse asked me that she would really 
appreciate extra training about medication and I 
am of course happy to provide that.” (field notes 
of the NDP).
The second strategy that we reconstructed was the identi-
fication of new patients. Based on specific observation of 
who initiated a patient consultation, we learned that the 
NDPs invited 69% of the patients for consultation. The GP 
initiated 13% of the consultations, other health care pro-
viders such as practice nurses initiated 7% and the patient 
initiated 11%. Hence, the NDPs do not seem to compete 
with practice nurses because the NDPs take up their own 
roles and identify their own distinct patient population. 
This is also reflected by the following:
“We regularly have interprofessional  consultations 
with both the GP, practice nurse and me. 
During these meetings we discuss the patient’s 
treatment plan, make priorities and divide tasks. 
This works really well.” (field notes of the NDP)
Clinical medication reviews
In the first months, the NDPs were instructed to focus 
their work of clinical medication reviews. They were asked 
to book a one-hour slot with patients for a clinical medica-
tion review. This hour would allow the NDP to study the 
whole patient record and especially a patient’s medication 
history. The GPs objected to a consultation of 60 minutes, 
and suggested a maximum of 20 minutes. Yet, the NDPs 
stressed that they needed more than an hour to discuss 
multiple problems, assess data, to contact other caregivers 
and make a sound clinical judgment. They compared their 
role with the role of a geriatric specialist, who can spend 
three hours on one patient. As an NDP explained:
“We try to unravel the puzzle, that takes time that 
is our strength. The GPs in my practice value the 
work that I do for patients.” (field notes of the NDP)
However, the importance to align with the work schedule 
of the GP practice is mentioned as well:
“On busy days, when a lot of patient consultations 
are scheduled, it is challenging to oversee all the 
patients. I am afraid to make mistakes. But I just 
need to learn to cope with this. This is how it works 
in general practice.” (field notes of the NDP)
By gaining more experience, the time of the intake 
 consultation diminished, as noted by one of the NDPs:
“Today, the intake consultation only took 35  minutes. 
I am satisfied about the flow of the  consultation and 
how we defined and  prioritized the patient’s prob-
lems. In my experience, the  consultation was very 
efficient. An intake of less than 30 minutes feels to 
be impossible though.” (field notes of the NDP)
Over time the clinical medication review developed in 
series of meetings. A clinical medication review consists 
on average of an intake consultation of 30 to 60 minutes 
in the patient’s home or in the general practice, followed 
by two to three short follow-up meetings in the patient’s 
home, by telephone or in the general practice.
Clinical quality management
We asked the NDPs to introduce medication therapy 
 quality management into their practice. As community 
pharmacists, the NDPs were already trained in quality 
management. We asked the NDPs to observe which clini-
cal skills were relevant for quality management in general 
practices. One particular skill became prominent in the 
Hazen et al: How Clinical Integration of Pharmacists in General 
Practice has Impact on Medication Therapy Management
Art. 1, page 5 of 8
analysis of the different quality projects that the NDPs 
started. This skill was to invite patients to the clinic for 
medication therapy management.
“It is not easy to ask a patient to come to the 
clinic for a medication review. Some patients are 
not inclined to come. They are content with the 
 medication they use.” (field notes of the NDP).
Patients tended not to come to the practice when they 
were invited to change or discontinue their medication 
therapy. Another NDP explained:
“I took the lead in implementing a quality project 
about the overtreatment with proton pump inhibi-
tors. Instead of a list with eligible patients – that 
will often just pile up on the desk of the GP – I 
consulted almost all of the patients and evaluated 
their medication use.” (field notes of the NDP).
For a successful conduct of a quality project, it was 
 necessary to thoroughly screen for eligible patients. 
An NDP stated:
“I do not particularly like the paperwork that 
comes with implementing a quality improvement 
project. The screening of eligible patients is very 
time consuming. But I realize that part needs to 
be done to perform clinical patient consultations.” 
(field notes of the NDP)
Rather than discussing whether medication should 
be stopped or changed, the NDP needed to start the 
 consultation by discussing symptoms that might bother 
patients and then assess their needs regarding these symp-
toms. A good example was a quality management project 
that all NDPs performed on the use of alpha-blockers for 
lower urinary tract symptoms. The NDPs selected patients 
from the general practice who were prescribed medica-
tion for lower urinary tract symptoms and invited them 
to evaluate their medication use. By discussing symptoms 
and the effect of medication therapy, the NDPs experi-
enced that the patients were more likely to discuss their 
medication-related needs, identify medication related 
problems and actually change their medication use.
Discussion
As the success of integrated pharmaceutical care is depen-
dent on how NDPs collaborate with GPs and practice 
nurses, how their work processes are aligned and thus 
how tasks are reallocated, we studied how NDPs perceive 
their interactions with GPs and practice nurses. Based 
upon observation notes made by the NDPs in their daily 
work at the clinic, we showed that NDPs need to bring 
first and for all clinical pharmaceutical expertise into gen-
eral practice. Moreover, integrating quality management 
into clinical work is key to successfully align work pro-
cesses and is the basis for task allocation. Paradoxically, 
full integration requires from NDPs to develop a distinct 
role in general practice.
Based upon the comparison of interactions with GPs 
and practice nurses that were perceived as successful, 
we showed that NDPs can share knowledge effectively in 
two distinct ways. First, NDPs need to mobilize pharma-
ceutical evidence on the spot. To collaborate successfully 
with GPs they need to provide direct answers to questions 
with regard to medication. Second, NDPs need to offer 
tailored solutions for problems of individual patients. 
Thereby, NDPs need to show that they can deviate from 
protocols if necessary and provide additional checks that 
allow deviation from the protocols.
Based upon the comparison of interactions with GPs 
and practice nurses over time, we showed that NDPs rec-
oncile interprofessional tensions on time and tasks by 
framing their work as quality management. Hence, the 
integration of NDPs in general practice depends on 
their experience in quality management and their abil-
ity to apply this in the clinical setting of the general 
practice [23]. NDPs integrate managerial skills and 
clinical skills in medication therapy management and 
in quality improvement projects for patient at risk. 
Consequently, they provide care to a distinct patient 
population that is elderly patients with polypharmacy 
and  multi-morbidities [23].
Although this was not the aim of this study, we noticed 
remarkably little resistance and tensions about role and 
responsibilities between community pharmacists and 
NDPs. Their roles can be complementary. Community 
pharmacists focus on dispensing medication, providing 
patient information and basic medication therapy man-
agement with incidental patient follow-up. NDPs focus 
on complex medication therapy management and patient 
consultations with structured follow-up.
This study adds to the literature on training in clini-
cal pharmacy. Training in North-America, Australia, New 
Zeeland and the United Kingdom [9, 12, 18, 24–28]. 
showed considerable variety. This study shows the impor-
tance of training clinical pharmacists to make evidence-
based decisions in which they combine their knowledge 
of medication with their clinical experience, taking into 
account the context and the needs of the patient [29]. 
We assume that training in clinical reasoning and con-
sultation skills [30, 31] are key to shared decision mak-
ing. The conceptual distinction between evidence and 
expertise is hereby relevant [32]. Evidence refers to the 
facts that can be transferred from one domain to the 
other – such as the active mechanism of a pharmaceuti-
cal, its benefits for a defined patient population and its 
possible side effects. Expertise is the professional ability 
to make judgments within a specific context [33], such as 
the decision to deviate from a prescription guideline or to 
suggest a non-pharmaceutical solution [34].
Previous research highlighted the challenge of over-
lapping roles between pharmacists and other health 
professionals, such as practice nurses, which could 
lead to conflicts [35]. This study shows that NDPs will 
not substitute care presently provided by GPs or prac-
tice nurses as they develop a distinct role. First, NDPs 
who integrate clinical pharmaceutical quality manage-
ment into their role provide a complementary skill set 
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to GPs and practice nurses. Second, they provide care to 
a distinct patient population, namely patients with mul-
tiple conditions who are at risk of medication-related 
problems. In fact, the added value of the integration on 
NDPs depends on the patient populations they identify. 
Previous research showed convincing evidence on phar-
macist-led services for patients with a specific condi-
tion or specific medication [9, 18, 36]. Yet, the literature 
also showed that patients at risk of medication-related 
problems often have multiple conditions and polyphar-
macy and require a comprehensive medication therapy 
management approach. Given the considerable variety 
in the specific services that NDPs performed and their 
degree of (clinical) integration [9, 12, 18, 24–28], this 
study underlines the need to address the distinct role of 
NDPs in general practice. The expertise of pharmacists 
can be better used when they have full responsibility for 
pharmaceutical care provision [37].
This study has limitations. First, the data in this 
study was collected by the NDPs and not by experi-
enced researchers. Hence, the observation notes were 
less detailed. In addition, the focus of the study is 
limited to the perception of NDPs. How GPs and prac-
tice nurses perceived the interactions with NDPs is 
not addressed in this study. Similarly, the perception 
of patients is not taken into account. Studies on the 
effect of this integrated care mode on patient-related 
outcome  measures are needed.
Conclusion
The success of integrated pharmaceutical care is depen-
dent on how NDPs collaborate with GPs and practice 
nurses. NDPs need to mobilize clinical  pharmaceutical 
expertise into general practice. Yet, integrating quality 
management into clinical work is key to integrate phar-
maceutical care. Paradoxically, full integration requires 
from NDPs to develop a distinct role in  general practice.
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